Impact of Proposed NIH Funding Cuts on Medical Research

The article discusses the impact of proposed NIH funding cuts on medical research and highlights the achievements made possible by NIH funding. Two deans from major medical institutions express concern about the potential devastating effects of the cuts on patients and medical breakthroughs.

Aspirin's Role in Fighting Cancer

Scientists have discovered that aspirin can enhance the immune system's ability to fight cancer by disrupting platelets and allowing T-cells to target and destroy spreading cancer cells. Clinical trials are ongoing to determine the effectiveness and risks of using aspirin in cancer treatment.

Disparities in Dementia Diagnosis Rates Across the U.S.

A new study shows that the likelihood of receiving a formal dementia diagnosis in the U.S. varies based on location, impacting access to treatments and clinical trials. Factors such as stigma and access to specialists may play a role in the disparities.

Alzheimer's Drug Donanemab

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel. The drug is designed to treat symptoms of early Alzheimer’s disease and has shown promising results in clinical trials.

Misinterpretation of Biden's Reference to mRNA Cancer Vaccines

President Joe Biden's reference to mRNA cancer vaccines during his State of the Union address was misinterpreted on social media, leading to false claims that COVID-19 vaccines are being used to cure cancer. In reality, mRNA technology used in COVID-19 vaccines is being studied to treat cancer, with promising results in clinical trials for different types of cancers.

New Male Contraceptive Method

Researchers at the Salk Institute have developed a promising new method for male contraception that is safe, effective, and reversible. The method targets a specific protein complex involved in sperm production without impacting other aspects of reproductive health. Clinical trials are still needed before it reaches the market.